<DOC>
	<DOCNO>NCT00092898</DOCNO>
	<brief_summary>This 6-month study patient rare disease , sitosterolemia may result heart-related disease . These patient unusually high absorption non-cholesterol sterol , result heart-related disease . This study investigate whether absorption non-cholesterols reduce patient .</brief_summary>
	<brief_title>An Investigational Drug Study Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia ( 0653-062 ) ( COMPLETED )</brief_title>
	<detailed_description>The duration treatment 26 week .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Lipid Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>18 year old , history elevate sitosterol level receive treatment least 6 month prior study entry . Patient condition , opinion investigator , might pose risk patient interfere participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Sitosterolemia</keyword>
</DOC>